ULISSE BIOMED SPA (UBM.MI) Forecast, Price Target & Analyst Ratings

BIT:UBM • IT0005451213

Current stock price

0.8 EUR
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ULISSE BIOMED SPA (UBM.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€1.52
+ 89.98% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€1.52
Upside
+ 89.98%
From current price of €0.80 to mean target of €1.52, Based on 5 analyst forecasts
Low
€1.50
Median
€1.52
High
€1.56

Price Target Revisions

1 Month
20.65%
3 Months
36.70%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for UBM.MI. The average price target is 1.52 EUR. This implies a price increase of 89.98% is expected in the next year compared to the current price of 0.8.
The average price target has been revised upward by 36.7% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

UBM Current Analyst RatingUBM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5

Analyst Ratings History

UBM Historical Analyst RatingsUBM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -6 -5 -4 -3 -2 -1 0 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
UBM.MI was analyzed by 5 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about UBM.MI.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed UBM.MI. So this is just the average opinion of a couple of analysts.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
UBM.MI revenue by date.UBM.MI revenue by date.
138.4K
-49.96%		66.2K
-52.17%		767.9K
1,059.97%		1.01M
31.53%		2.02M
100.00%		5.05M
150.00%
EBITDA
YoY % growth
UBM.MI ebitda by date.UBM.MI ebitda by date.
-986.8K
-177.42%		-2.293M
-132.41%		-2.988M
-30.28%		-1.01M
66.20%		-1.01M
100.00%
EBIT
YoY % growth
UBM.MI ebit by date.UBM.MI ebit by date.
-1.306M
-116.51%		-4.797M
-267.15%		-5.911M
-23.24%		-1.01M
82.91%		-1.01M
100.00%
Operating Margin
UBM.MI operating margin by date.UBM.MI operating margin by date.
-943.93%-7,245.47%-769.77%-100.00%-50.00%N/A
EPS
YoY % growth
UBM.MI eps by date.UBM.MI eps by date.
N/AN/AN/A-0.04-0.03
8.11%		0.00
102.94%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

UBM.MI Yearly Revenue VS EstimatesUBM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 1M 2M 3M 4M 5M
UBM.MI Yearly EPS VS EstimatesUBM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -0.01 -0.02 -0.03

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.08%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
59.01%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
25.99%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ULISSE BIOMED SPA / UBM.MI Forecast FAQ

What do analysts expect the price target to be for ULISSE BIOMED SPA (UBM.MI)?

5 analysts have analysed UBM.MI and the average price target is 1.52 EUR. This implies a price increase of 89.98% is expected in the next year compared to the current price of 0.8.

Can you provide the consensus rating for ULISSE BIOMED SPA stock?

The consensus rating for ULISSE BIOMED SPA (UBM.MI) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.